(Q31020589)

28 June 2017

1 reference

title

What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review (English)

1 reference

28 June 2017

0 references

John M Ringman

1

1 reference

28 June 2017

1 December 2005

1 reference

Journal of Geriatric Psychiatry and Neurology

28 June 2017

1 reference

28 June 2017

18

1 reference

28 June 2017

4

1 reference

28 June 2017

228-233

1 reference

Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.

28 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Presenilins in memory, Alzheimer's disease, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Neuropsychological changes in subjects at risk of inheriting Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Neuropsychological function in nondemented carriers of presenilin-1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Assessing the onset of structural change in familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

Positron emission tomography in familial Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988705281878

21 January 2018

Identifiers

DOI

10.1177/0891988705281878

1 reference

28 June 2017

1 reference

PubMed ID

16306245